Vaccine breakthrough stops cancer returning in trial

A new vaccine breakthrough has shown promising results in extending the duration that cancer patients remain cancer-free during clinical trials. However, researchers have not yet determined the long-term duration of this protective effect. The findings suggest potential for improved cancer treatment outcomes, though further study is needed.